Navigation Links
CNIO researchers describe new functions of cohesin relevant for human disease
Date:5/3/2012

Cohesin is a ring-shaped protein complex involved in the spatial organization of the genome and in mitotic chromosome structure. Vertebrate somatic cells have two versions of cohesin that contain either SA1 or SA2, but their functional specificity has been largely ignored. Researchers of the Spanish National Cancer Research Centre (CNIO) under the direction of Ana Losada have identified new functions of cohesin SA1 that are relevant for two human diseases, cancer and Cornelia de Lange Syndrome (CdLS). These results are published in two papers that appear this week back-to-back in EMBO Journal.

The first study shows that SA1 is required for efficient duplication of chromosome ends, the telomeres. In its absence, aberrant telomere structures hinder chromosome segregation during cell division and aneuploid cells (i.e., with an incorrect number of chromosomes) are generated. This aneuploidy likely contributes to accelerate the onset of tumourigenesis in SA1 deficient mice. The appearance of certain types of pancreatic tumours, extremely rare in mice, is particularly striking. This mouse model may turn out to be a very useful tool for the study of pancreatic cancer.

The second study reports for the first time a precise map of the distribution of cohesin SA1 and cohesin SA2 along the mouse genome. Moreover, it uncovers an essential role of cohesin SA1 in the regulation of gene expression during embryonic development. Lack of cohesin SA1 alters the transcription of genes involved in biological processes related to CdLS. This developmental disorder affects 1:30,000 newborns and is characterized by growth and mental retardation and multiple organ abnormalities. The study offers new clues to understand the origin of the pathologies observed in CdLS patients.

"This work represents an important step towards better understating the role of cohesin in such relevant human diseases as cancer and CdLS", comment Silvia Remeseiro and Ana Cuadr
'/>"/>

Contact: Juan J. Gomez
juanj.gomez@cnio.es
34-917-328-000-4060
Centro Nacional de Investigaciones Oncologicas (CNIO)
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Biomedical researchers receive Hartwell Foundation awards
2. Kessler Foundation researchers present at first International Congress on Cognition in MS
3. Researchers gain better understanding of mechanism behind tau spreading in the brain
4. Moffitt Cancer Center researchers identify drivers of sarcoma growth and survival
5. Researchers determine vitamin D blood level for reducing major medical risks in older adults
6. Researchers creating designer lymph nodes based on Moffitts Total Cancer Care initiative
7. Moffitt researchers find adolescents with cancer concerned about their future reproductive health
8. Moffitt Cancer Center researchers working at frontiers of melanoma research
9. Moffitt Cancer Center researchers: Quality of life as important as quantity of life
10. UCLA researchers combat global disease with a cell phone, Google Maps and a lot of ingenuity
11. Spinal cord injury researchers win Apple Award for article on niacin for dyslipidemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... 11, 2014 When the mercury rises, heat ... driving engine, the heart, takes on a heavier load in ... July 2014 issue of the Harvard Men's Health Watch ... requires no more than knowing their limits and drinking enough ... going to be more sensitive to the heat," says Dr. ...
(Date:7/11/2014)... Angeles, CA (PRWEB) July 11, 2014 ... Sands today announces that he uses mini and full ... treatments offer the defining feature that distinguishes dental implants ... teeth in addition to the crowns. This alone prevents ... implants also offer advantages related to comfort, appearance ...
(Date:7/11/2014)... -- A new study challenges the widely held belief that ... Researchers analyzed more than 50 studies that examined drinking ... They found that those with a form of a gene ... The gene affects how a person,s body breaks down alcohol, ... Having this variant has been shown to lead to lower ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Cancer researchers ... have a significant impact on how patients respond to ... for mesothelioma. Surviving Mesothelioma has the full story. ... , Researchers at the University of Ljubljana and the ... pemetrexed for different types of polymorphisms. They found ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 Anterior Cruciate ... year, but the type of material used to create ... in the game, say researchers presenting their work today ... of Sports Medicine ( AOSSM ). , ... population, allografts (tissue harvested from a donor) fail more ...
Breaking Medicine News(10 mins):Health News:Take Common Sense Steps to Stay Safe This Summer, from the July 2014 Harvard Men's Health Watch 2Health News:Take Common Sense Steps to Stay Safe This Summer, from the July 2014 Harvard Men's Health Watch 3Health News:Dental Implant Dentist, Kevin Sands DDS, Now Uses Mini and Full Mouth Implants to Replace Missing Teeth 2Health News:A Little Alcohol May Not Be Good for Your Heart After All 2Health News:New Research Finds Genetic Variables Impact Chemotherapy Response, According to Surviving Mesothelioma 2Health News:ACL Reconstructions May Last Longer With Autografts 2
... Hello Kitty, the moon-faced cartoon cat turned global icon of ... yen (32,000 dollars) for the ultimate pampered pooch . ... and a cushion bearing Hello Kitty's face, will be put ... Sanrio Co. said. ,Sanrio designer Ikuko Shimizu launched ...
... high-risk of having a heart attack are unclear about when ... an ambulance , argue a group of heart specialists in ... who die from coronary heart disease have had previous heart ... Foundation shows that 40% of the general population would not ...
... new score for predicting the risk of heart disease gives ... at risk of developing the disease and which adults are ... study published on bmj.com today, estimates that in the general ... million adults under the age of 75 in Britain at ...
... number of studies have suggested that regular exercise reduces inflammation ... other diseases, such as diabetes its still not clear ... link exists, the nature of the relationship is by no ... and community health researchers at the University of Illinois provides ...
... a medical device company founded in 2004 to bring ... surgical markets, announced that vascular surgeons at the ... clinically use their novel high performance vascular sealant, ArterX(TM). ... a 74 year old man suffering from vascular insufficiency ...
... has constituted rapid response teams to combat diseases of all ... teams have been formed to combat both contagious and non-contagious ... (IDSP)," Madhya Pradesh health minister Ajay Vishnoi told IANS. ... 2004 with an objective to compile survey work and immediate ...
Cached Medicine News:Health News:High-risk Patients Need Better Guidance on What is and Isnt a Heart Attack 2Health News:New Heart Disease Risk Score Will Help Minimise Health Inequalities 2Health News:New Heart Disease Risk Score Will Help Minimise Health Inequalities 3Health News:Exercise Reduces Inflammation 2Health News:Exercise Reduces Inflammation 3Health News:Exercise Reduces Inflammation 4Health News:Tenaxis Medical Inc. Announces First Human Use of Vascular Sealant 2
(Date:7/11/2014)... , July 11, 2014  Australian drug delivery company, ... it has raised A$19.3 million via a placement of ... , the U.S., Asia ... from a share purchase plan (SPP) to be offered ... be made in two tranches. "This capital ...
(Date:7/11/2014)... 11, 2014 On Thursday, ... 0.52%, the Dow Jones Industrial Average finished the day 0.42% ... down 0.41%. The losses were broad based as eight out ... 500 Health Care Sector Index ended the day at 711.88, ... last one month. Investor-Edge has initiated coverage on the following ...
(Date:7/11/2014)... 2014 According to a new ... Market (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) - ... 2013-2019" the global endoscopy devices market was valued at ... grow at a CAGR of 6.8% from 2013 to ... billion in 2019. Browse the full Endoscopy ...
Breaking Medicine Technology:Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 2Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 3Health Care Equipment Equities Movers and Shakers -- Research on Covidien, Baxter, DexCom, and Boston Scientific 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6
... levels following 4 weeks of, treatment with R7128 1500mg and Pegasys(R) plus ... tolerability comparable to ... - Conference Call Scheduled for 4:00PM ET Today -, PRINCETON, N.J., ... of a 4-week Phase 1,clinical trial to evaluate two oral dose levels ...
... Duration of ... Neutropenia- ... Jan. 7 Maxygen, Inc.,(Nasdaq: MAXY ) today announced positive progress in ... the trial include the following:, -- Patients in the initial 10 ...
Cached Medicine Technology:Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C 2Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C 3Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C 4Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C 5Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C 6Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF 2Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF 3Maxygen Announces Positive Progress in Phase IIa Clinical Trial of Novel PEG-GCSF 4
The Professional ophthalmoscope has been designed to ensure ultimate control. Lenses, graticules and filters can all be introduced at the touch of a fingertip without the need to pull away from the p...
... Sprint Automated Urine Microscopy Analyzer (iQ200 Sprint) ... Series. The analyzer uses digital imaging and ... particles into 12 categories and quantitatively report ... time used to prepare and interpret urine ...
A flexible hematology platform:, 32 parameters, Automatic result validation, Cytology atlas included, CBC and 5+3 DIFF...
StarClose Clip Applier, (includes), Clip Applier, 6F Exchange Sheath, 6F Dilator, 0.038 50 cm J-Tip Guide Wire ...
Medicine Products: